US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
In late-January, the US suspended billions of dollars worth of international aid, including for HIV-related programmes in South Africa. The South African government could have responded by triggering an emergency funding mechanism but has failed to do so yet. In the meantime, activists, health researchers and even technical advisors to government are growing increasingly frustrated with the government’s lack of transparency on this issue.
Top local researchers estimate that the cancellation of funding from the US President’s Emergency Plan for AIDS Relief could lead to a significant increase in HIV infections and deaths in South Africa. Jesse Copelyn reports.
People who live near Thusong District Hospital, which closed in 2022, and the Christiana District Hospital, which was destroyed by fire in 2021, told Spotlight’s Nthusang Lefafa they are frustrated over long ambulance wait times, overcrowded clinics, and the high cost of traveling to alternative healthcare facilities
There is no shortage of myths about the cancellation of US foreign assistance. This includes the widely held misconception that PEPFAR is exempt from US aid cuts and the belief that grant terminations are just taking place in South Africa. Many of these falsehoods have been reinforced by US and South African officials. Spotlight and GroundUp dissect some of the most popular misconceptions.
After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck than the government’s programmes. Jesse Copelyn looks past the 17% figure, and considers how the health system is being affected by the loss of US money.
Medical aid schemes will be given collective power to negotiate prices, according to draft regulations published last week. While some see the move as an important step toward reining in private healthcare prices, others argue that they do not go far enough and are legally unsound. Chris Bateman spoke to several leading experts about the proposed reforms.
South Africa’s National Department of Health is still to outline a clear contingency plan as a US funding freeze puts lives at risk, spells job losses, and presents threats to keeping HIV and TB under control. Ufrieda Ho reports.
A coalition of health service organisations has warned that patients will lose access to life-saving treatment if the US withdraws health funding to South Africa. Certain HIV and TB-related health services are continuing for now under a limited waiver. But the waiver has failed to cover organisations that provide services, including HIV care, specifically to LGBTI people and people who inject drugs. Two PEPFAR-funded harm reduction centres have already closed their doors, as have health service organisations that support LGBTI people.
A timely report on governance in South Africa’s healthcare sector released last year identified several serious shortcomings. As the political and administrative wheels again start turning in 2025, Elri Voigt unpacks the report and asks if government is paying attention.
From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South Africa and around the globe. Here’s Spotlight’s top four healthcare questions for 2025.
Professor Lucy Gilson scooped the prestigious international Virchow Prize. She chats to Biénne Huisman about her upbringing, unexpected dive into the world of public health, and shares her thoughts on National Health Insurance. She says it will take more than money to fix our health system.
